These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 7073946)
41. Differential cell-cycle-dependent inhibition of DNA synthesis by hydroxyurea and cytosine arabinoside in cultured L5178Y mouse lymphoma cells. Malec J; Kornacka L; Sawecka J Arch Immunol Ther Exp (Warsz); 1979; 27(4):539-45. PubMed ID: 518260 [TBL] [Abstract][Full Text] [Related]
42. Paradoxical effect of 1-beta-D-arabinofuranosyl cytosine triphosphate on bleomycin-induced unscheduled DNA synthesis in permeable sarcoma cells. Seki S; Iwamoto H; Maki Y; Oda T Experientia; 1982 Jun; 38(6):657-8. PubMed ID: 6179783 [No Abstract] [Full Text] [Related]
43. Sequence-specific effects of ara-5-aza-CTP and ara-CTP on DNA synthesis by purified human DNA polymerases in vitro: visualization of chain elongation on a defined template. Townsend AJ; Cheng YC Mol Pharmacol; 1987 Sep; 32(3):330-9. PubMed ID: 2444869 [TBL] [Abstract][Full Text] [Related]
44. Inhibition of cationic liposomes of [3H]thymidine incorporation into DNA of L1210 cells. Laurent G; Laduron C; Ruysschaert JM; Deleers M Res Commun Chem Pathol Pharmacol; 1981 Mar; 31(3):515-27. PubMed ID: 7255883 [TBL] [Abstract][Full Text] [Related]
45. Role of deoxycytidine kinase in the inhibitory activity of 5-substituted 2'-deoxycytidines and cytosine arabinosides on tumor cell growth. Balzarini J; De Clercq E Mol Pharmacol; 1983 Jan; 23(1):175-81. PubMed ID: 6306422 [TBL] [Abstract][Full Text] [Related]
46. In vitro drug sensitivity of tumor cells is correlated with drug-induced inhibition of DNA synthesis. Brown DB; Rao PN Yale J Biol Med; 1984; 57(6):825-32. PubMed ID: 6537691 [TBL] [Abstract][Full Text] [Related]
47. Characterization of a multidrug resistant human erythroleukemia cell line (K562) exhibiting spontaneous resistance to 1-beta-D-arabinofuranosylcytosine. Grant S; Turner A; Nelms P; Yanovich S Leukemia; 1995 May; 9(5):808-14. PubMed ID: 7769843 [TBL] [Abstract][Full Text] [Related]
48. Inhibition of DNA primase by nucleoside triphosphates and their arabinofuranosyl analogs. Parker WB; Cheng YC Mol Pharmacol; 1987 Feb; 31(2):146-51. PubMed ID: 3807892 [TBL] [Abstract][Full Text] [Related]
49. Two distinct molecular mechanisms underlying cytarabine resistance in human leukemic cells. Cai J; Damaraju VL; Groulx N; Mowles D; Peng Y; Robins MJ; Cass CE; Gros P Cancer Res; 2008 Apr; 68(7):2349-57. PubMed ID: 18381442 [TBL] [Abstract][Full Text] [Related]
50. No preferential sensitivity of t(8;21) acute myeloid leukemias to cytosine arabinoside in vitro: is intensity of therapy or high dose Ara-C crucial for response? Visani G; Isidori A; Grafone T; Tosi P; Santini V; Malagola M; Martinelli G; Piccaluga PP; Gaziev D; Ottaviani E; Sparaventi G; Tura S Leuk Lymphoma; 2004 Jul; 45(7):1361-4. PubMed ID: 15359633 [TBL] [Abstract][Full Text] [Related]
51. Activation of deoxycytidylate deaminase by 1-beta-D-arabinofuranosylcytosine-5'-triphosphate. George CB; Cory JG Biochem Pharmacol; 1979 May; 28(10):1699-701. PubMed ID: 475831 [No Abstract] [Full Text] [Related]
52. Characterization of protein and DNA in P815 cells sensitive and resistant to 1- -D-arabinofuranosylcytosine. Kreis W; Drahovsky D; Borberg H Cancer Res; 1972 Apr; 32(4):696-701. PubMed ID: 4622581 [No Abstract] [Full Text] [Related]
53. Role of deoxycytidine kinase in an in vitro model for AraC- and DAC-resistance: substrate-enzyme interactions with deoxycytidine, 1-beta-D-arabinofuranosylcytosine and 5-aza-2'-deoxycytidine. Stegmann AP; Honders MW; Kester MG; Landegent JE; Willemze R Leukemia; 1993 Jul; 7(7):1005-11. PubMed ID: 7686601 [TBL] [Abstract][Full Text] [Related]
54. Development of a sensitive and selective LC/MS/MS method for the simultaneous determination of intracellular 1-beta-D-arabinofuranosylcytosine triphosphate (araCTP), cytidine triphosphate (CTP) and deoxycytidine triphosphate (dCTP) in a human follicular lymphoma cell line. Crauste C; Lefebvre I; Hovaneissian M; Puy JY; Roy B; Peyrottes S; Cohen S; Guitton J; Dumontet C; Perigaud C J Chromatogr B Analyt Technol Biomed Life Sci; 2009 May; 877(14-15):1417-25. PubMed ID: 19328748 [TBL] [Abstract][Full Text] [Related]
55. Enhanced autophagy in cytarabine arabinoside-resistant U937 leukemia cells and its potential as a target for overcoming resistance. Cheong JW; Kim Y; Eom JI; Jeung HK; Min YH Mol Med Rep; 2016 Apr; 13(4):3433-40. PubMed ID: 26935591 [TBL] [Abstract][Full Text] [Related]
56. Increase in the cytotoxicity of 1-beta-D-arabinofuranosylcytosine due to inhibition of degradation of its triphosphate by hydroxyurea in Burkitt's lymphoma cells. Abe I; Saito S; Suzuki M; Sato H Gan; 1981 Apr; 72(2):337-8. PubMed ID: 7286558 [No Abstract] [Full Text] [Related]
57. A radioimmunoassay for cytosine arabinoside. Piall EM; Aherne GW; Marks VM Br J Cancer; 1979 Oct; 40(4):548-56. PubMed ID: 574019 [TBL] [Abstract][Full Text] [Related]
58. Effect of thymidine on the sensitivity of cultured mouse tumor cells to 1-beta-D-arabinofuranosylcytosine. Harris AW; Reynolds EC; Finch LR Cancer Res; 1979 Feb; 39(2 Pt 1):538-41. PubMed ID: 761229 [TBL] [Abstract][Full Text] [Related]
59. Cell cycle-dependent cytotoxicity and induction of apoptosis by liposomal N4-hexadecyl-1-beta-D-arabinofuranosylcytosine. Horber DH; von Ballmoos P; Schott H; Schwendener RA Br J Cancer; 1995 Nov; 72(5):1067-73. PubMed ID: 7577448 [TBL] [Abstract][Full Text] [Related]
60. Sensitivity of the DNA polymerase activities of Tetrahymena pyriformis to cytosine arabinoside triphosphate and N-ethyl-maleiimide. Benhura MA Pharmazie; 1995 Mar; 50(3):213-5. PubMed ID: 7732054 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]